Top compounds associated with response to OR10A7


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.012 0.7
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.011 0.7
mRNA CHM-1 CTRPv2 pan-cancer AAC -0.011 0.7
mRNA PF-750 CTRPv2 pan-cancer AAC 0.013 0.7
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.013 0.7
mRNA BIBR-1532 CTRPv2 pan-cancer AAC -0.013 0.7
mRNA SNX-2112 CTRPv2 pan-cancer AAC 0.011 0.7
mRNA erismodegib CTRPv2 pan-cancer AAC -0.013 0.7
mRNA Bortezomib CTRPv2 pan-cancer AAC -0.012 0.7
mRNA azacitidine CTRPv2 pan-cancer AAC -0.013 0.7
Download CSV